Ideaya Biosciences Correlations
IDYA Stock | USD 26.66 0.79 2.88% |
The current 90-days correlation between Ideaya Biosciences and AnaptysBio is 0.29 (i.e., Modest diversification). The correlation of Ideaya Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Ideaya Biosciences Correlation With Market
Very weak diversification
The correlation between Ideaya Biosciences and DJI is 0.42 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ideaya Biosciences and DJI in the same portfolio, assuming nothing else is changed.
Ideaya |
Moving together with Ideaya Stock
0.71 | ME | 23Andme Holding | PairCorr |
0.84 | VALN | Valneva SE ADR | PairCorr |
0.69 | VCNX | Vaccinex Trending | PairCorr |
0.73 | DRMA | Dermata Therapeutics | PairCorr |
0.78 | DRRX | Durect | PairCorr |
0.89 | DTIL | Precision BioSciences | PairCorr |
0.8 | VINC | Vincerx Pharma | PairCorr |
0.62 | VIRX | Viracta Therapeutics | PairCorr |
0.77 | VRAX | Virax Biolabs Group | PairCorr |
0.79 | VRCA | Verrica Pharmaceuticals | PairCorr |
0.69 | VRPX | Virpax Pharmaceuticals | PairCorr |
0.81 | VTGN | VistaGen Therapeutics | PairCorr |
Moving against Ideaya Stock
0.69 | VCYT | Veracyte | PairCorr |
0.64 | VERA | Vera Therapeutics | PairCorr |
0.63 | DRUG | Bright Minds Biosciences | PairCorr |
0.62 | SABSW | SAB Biotherapeutics | PairCorr |
0.44 | DMAC | DiaMedica Therapeutics | PairCorr |
0.35 | VANI | Vivani Medical | PairCorr |
0.35 | VCEL | Vericel Corp Ord | PairCorr |
0.75 | VRNA | Verona Pharma PLC | PairCorr |
0.68 | VSTM | Verastem Trending | PairCorr |
0.49 | VTRS | Viatris | PairCorr |
0.47 | VRDN | Viridian Therapeutics | PairCorr |
0.42 | DVAX | Dynavax Technologies | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Ideaya Stock performing well and Ideaya Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ideaya Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ANAB | 3.55 | (1.02) | 0.00 | (0.21) | 0.00 | 5.77 | 35.57 | |||
MGTX | 2.78 | 0.51 | 0.19 | 0.36 | 2.71 | 6.75 | 21.07 | |||
KROS | 2.27 | 0.38 | 0.16 | 0.39 | 2.19 | 5.38 | 16.94 | |||
FIXX | 2.82 | 0.07 | 0.01 | 0.20 | 3.52 | 5.77 | 19.43 | |||
VTYX | 3.46 | (0.02) | 0.04 | 0.10 | 3.32 | 6.96 | 29.27 | |||
PTGX | 1.98 | (0.20) | 0.00 | (0.02) | 0.00 | 3.70 | 14.61 | |||
VRNA | 2.11 | 0.51 | 0.21 | 1.58 | 1.74 | 7.31 | 14.37 | |||
SNDX | 2.27 | (0.49) | 0.00 | (0.10) | 0.00 | 4.02 | 34.00 | |||
CERE | 0.77 | 0.09 | (0.03) | (0.59) | 0.94 | 1.91 | 6.40 | |||
RNA | 3.01 | (0.31) | 0.00 | (0.07) | 0.00 | 5.78 | 27.94 |
Ideaya Biosciences Corporate Management
Mick OQuigley | Chief Development | Profile | |
Stu Dorman | Chief Officer | Profile | |
Paul Stone | CFO VP | Profile | |
JD Esq | Chief Secretary | Profile | |
Matthew MD | VP Oncology | Profile | |
Esq JD | Gen VP | Profile |